Apocynin, a low molecular oral treatment for neurodegenerative disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  'T Hart, Bert A ^a,b   Copray, Sjef ^b   Philippens, Ingrid ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; PHENOL DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ACETOPHENONE DERIVATIVE; CYBB PROTEIN, HUMAN; ENZYME INHIBITOR; MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; INFLAMMATORY DISEASE; JATROPHA; JATROPHA MULTIFIDA; MEDICINAL PLANT; MICROGLIA; NONHUMAN; PARKINSON DISEASE; PICRORHIZA KURROA; PRIMATE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NEURODEGENERATIVE DISEASES; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHAGOCYTE;

ACETOPHENONES; ADMINISTRATION, ORAL; ENZYME INHIBITORS; HUMANS; JATROPHA; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NEURODEGENERATIVE DISEASES; PHAGOCYTES; PLANTS, MEDICINAL; REACTIVE OXYGEN SPECIES;

EID: 84929050867     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/298020     Document Type: Article

References (42)

1. J. Drouin-Ouellet and F. Cicchetti, "Inflammation and neurodegeneration: the story retolled, " Trends in Pharmacological Sciences, vol. 33, no. 10, pp. 542-551, 2012.
2. J. M. Simons, L. A. Hart, H. Van Dijk, F. C. Fischer, K. T. D. De Silva, and R. P. Labadie, "Immunodulatory compounds from Picrorhiza kurroa: isolation and characterization of two anti-complementary polymeric fractions from an aqueous root extract, " Journal of Ethnopharmacology, vol. 26, no. 2, pp. 169-182, 1989.
3. B. M. Babior, "NADPH oxidase: an update, " Blood, vol. 93, no. 5, pp. 1464-1476, 1999.
4. L. A. t Hart, P. van Enckevort, K. P. M. vanKessel, H. vanDijk, and R. P. Labadie, "Evidence that superoxide-anion, produced by PMA-activated human polymorphonuclear leukocytes, is the cytolytic agent for rabbit, but not for sheep red blood cells, " Immunology Letters, vol. 18, no. 2, pp. 139-144, 1988.
5. M. B. Hampton, A. J. Kettle, and C. C. Winterbourn, "Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing, " Blood, vol. 92, no. 9, pp. 3007-3017, 1998.
6. S. J. Weiss, "Tissue destruction by neutrophils, " The New England Journal of Medicine, vol. 320, no. 6, pp. 365-376, 1989.
7. J. M. Simons, B. A. Hart, T. R. A. M. Ip Vai Ching, H. van Dijk, and R. P. Labadie, "Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neurophils, " Free Radical Biology andMedicine, vol. 8, no. 3, pp. 251-258, 1990.
8. D. K. Johnson, K. J. Schillinger, D. M. Kwait et al., "Inhibition of NADPH oxidase activation in endothelial cells by orthomethoxy-substituted catechols, " Endothelium, vol. 9, no. 3, pp. 191-203, 2002.
9. D. Schrier, R. B. Gilbertsen, M. Lesch, and J. Fantone, "The role of neutrophils in type II collagen-induced arthritis in rats, " The American Journal of Pathology, vol. 117, no. 1, pp. 26-29, 1984.
10. B. A. THart, J. M. Simons, S. Knaan-Shanzer, N. P. M. Bakker, and R. P. Labadie, "Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin, " Free Radical Biology and Medicine, vol. 9, no. 2, pp. 127-131, 1990.
11. S. Hougee, A. Hartog, A. Sanders et al., "Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice, " European Journal of Pharmacology, vol. 531, no. 1-3, pp. 264-269, 2006.
12. B. A. Hart, J. G. R. Elferink, and P. H. Nibbering, "Effect of apocynin on the induction of ulcerative lesions in rat skin injected with tubercle bacteria, " International Journal of Immunopharmacology, vol. 14, no. 6, pp. 953-961, 1992.
13. R. M. Ransohoff and B. Engelhardt, "The anatomical and cellular basis of immune surveillance in the central nervous system, " Nature Reviews Immunology, vol. 12, no. 9, pp. 623-635, 2012.
14. M. Lamkanfi, "Emerging inflammasome effector mechanisms, " Nature Reviews Immunology, vol. 11, no. 3, pp. 213-220, 2011.
15. A. Nimmerjahn, F. Kirchhoff, and F. Helmchen, "Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, " Science, vol. 308, no. 5726, pp. 1314-1318, 2005.
16. P. L. McGeer and E. G. McGeer, "Inflammation and the degenerative diseases of aging, " Annals of theNewYork Academy of Sciences, vol. 1035, pp. 104-116, 2004.
17. P. L. McGeer and E. G. McGeer, "Glial reactions in Parkinson's disease, " Movement Disorders, vol. 23, no. 4, pp. 474-483, 2008.
18. B. A. Durafourt, C. S. Moore, D. A. Zammit et al., "Comparison of polarization properties of human adult microglia and bloodderived macrophages, " GLIA, vol. 60, no. 5, pp. 717-727, 2012.
19. J. Stefanska and R. Pawliczak, "Apocynin: molecular aptitudes, " Mediators of Inflammation, vol. 2008, Article ID 106507, 10 pages, 2008.
20. S. Pawate, Q. Shen, F. Fan, and N. R. Bhat, "Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ, " Journal of Neuroscience Research, vol. 77, no. 4, pp. 540-551, 2004.
21. P. K. Mander, A. Jekabsone, and G. C. Brown, "Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase, " Journal of Immunology, vol. 176, no. 2, pp. 1046-1052, 2006.
22. S. H. Choi, S. Aid, H. Kim, S. H. Jackson, and F. Bosetti, "Inhibition of NADPH oxidase promotes alternative and antiinflammatory microglial activation during neuroinflammation, " Journal of Neurochemistry, vol. 120, no. 2, pp. 292-301, 2012.
23. S. W. Barger, M. E. Goodwin, M. M. Porter, and M. L. Beggs, "Glutamate release fromactivated microglia requires the oxidative burst and lipid peroxidation, " Journal of Neurochemistry, vol. 101, no. 5, pp. 1205-1213, 2007
24. D. R. Rosen, T. Siddique, D. Patterson et al., "Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, " Nature, vol. 362, no. 6415, pp. 59-62, 1993.
25. J. Cooper-Knock, J. Kirby, L. Ferraiuolo, P. R. Heath, M. Rattray, and P. J. Shaw, "Gene expression profiling in human neurodegenerative disease, " Nature Reviews Neurology, vol. 8, no. 9, pp. 518-530, 2012.
26. J. D. Rothstein, L. Jin, M. Dykes-Hoberg, and R. W. Kuncl, "Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 14, pp. 6591-6595, 1993.
27. M. Nagai, D. B. Re, T. Nagata et al., "Astrocytes expressing ALSlinked mutated SOD1 release factors selectively toxic to motor neurons, " Nature Neuroscience, vol. 10, no. 5, pp. 615-622, 2007.
28. S. Boillee, K. Yamanaka, C. S. Lobsiger et al., "Onset and progression in inherited ALS determined bymotor neurons and microglia, " Science, vol. 312, no. 5778, pp. 1389-1392, 2006.
29. D. R. Beers, J. S. Henkel, Q. Xiao et al., "Wild-type microglia extend survival in PU. 1 knockout mice with familial amyotrophic lateral sclerosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 43, pp. 16021-16026, 2006.
30. M. M. Harraz, J. J. Marden, W. Zhou et al., "SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model, " Journal of Clinical Investigation, vol. 118, no. 2, pp. 659-670, 2008.
31. K. A. Trumbull, D. McAllister, M. M. Gandelman et al., "Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice, " Neurobiology of Disease, vol. 45, no. 1, pp. 137-144, 2012.
32. L. Minati, T. Edginton, M. Grazia Bruzzone, and G. Giaccone, "Reviews: current concepts in alzheimer's disease: a multidisciplinary review, " The American Journal of Alzheimer's Disease and other Dementias, vol. 24, no. 2, pp. 95-121, 2009.
33. B. L. Wilkinson, P. E. Cramer, N. H. Varvel et al., "Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimers disease, " Neurobiology of Aging, vol. 33, no. 1, pp. 197. e21-197. e32, 2012.
34. T. Schilling and C. Eder, "Amyloid-β-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia, " Journal of Cellular Physiology, vol. 226, no. 12, pp. 3295-3302, 2011.
35. S. Shimohama, H. Tanino, N. Kawakami et al., "Activation of NADPH oxidase in Alzheimers disease brains, " Biochemical and Biophysical Research Communications, vol. 273, no. 1, pp. 5-9, 2000.
36. M. E. Lull, S. Levesque, M. J. Surace, and M. L. Block, "Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)SL mice, " PLoS ONE, vol. 6, no. 5, Article ID e20153, 2011.
37. J. W. Langston, P. Ballard, J. W. Tetrud, and I. Irwin, "Chronic parkinsonism in humans due to a product of meperidineanalog synthesis, " Science, vol. 219, no. 4587, pp. 979-980, 1983.
38. R. L. Miller, M. James-Kracke, G. Y. Sun, and A. Y. Sun, "Oxidative and inflammatory pathways in parkinsons disease, " Neurochemical Research, vol. 34, no. 1, pp. 55-65, 2009.
39. H. Gao, B. Liu, W. Zhang, and J. Hong, "Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinsons disease, " The FASEB Journal, vol. 17, no. 13, pp. 1954-1956, 2003.
40. H. Gao, B. Liu, W. Zhang, and J. Hong, "Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinsons disease, "TheFASEB Journal, vol. 17, no. 13, pp. 1957-1959, 2003.
41. I. H. C. H. M. Philippens, B. A. t Hart, and G. Torres, "The MPTPmarmosetmodel of Parkinsonism: amulti-purpose nonhuman primate model for neurodegenerative diseases, " Drug Discovery Today, vol. 15, no. 23-24, pp. 985-990, 2010.
42. E. A. Peters, J. T. N. Hiltermann, and J. Stolk, "Effect of apocynin on ozone-induced airway hyperresponsiveness tomethacholine in asthmatics, " Free Radical Biology and Medicine, vol. 31, no. 11, pp. 1442-1447, 2001.